Griffith University

Book chapters

1. Masters, C.; Crane, D. The peroxisome: a vital organelle. Cambridge University Press: Cambridge, 1995; p 286.

Refereed journal articles

1. Mueller, C.C.; Nguyen, T.H.; Ahlemeyer, B.; Meshram, M.; Santrampurwala, N.; Cao, S.; Sharp, P.; Fietz, P.B.; Baumgart-Vogt, E.; Crane, D.I. PEX13-deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress. Disease Models Mech (in press) 2010.
2. Gobe, G.; Crane, D. Mitochondria, reactive oxygen species and cadmium toxicity in the kidney. Toxicol Lett 2010, 198, 49-55.
3. McDonald, C.; Mackay-Sim, A.; Crane, D.; Murrell, W. Could cells from your nose fix your heart? Transplantation of olfactory stem cells in a rat model of cardiac infarction. Scientific World Journal 2010, 10, 422-433.
4. Yakunin, E.; Moser, A.; Loeb, V.; Reisch, A.S.; Faust, P.; Crane, D.I.; Baes, M.; Sharon, R. Alpha-Synuclein Abnormalities in Mouse Models of Peroxisome Biogenesis Disorders: Implications for the Involvement of Peroxisomes in Parkinson’s Disease. J Neurosci Res 2010, 88, 866-876.
5. Müller, C.C.; Nourse, J.P.; Nguyen, T.H.; Crane, D.I. Quantitative genotyping of mouse brain-specific PEX13 gene disruption by real-time PCR. J Neurosci Meth 2009, 181, 73–81.
6. Pham, T.D.; Müller, C.C. and Crane, D.I. Fuzzy scaling analysis of a mouse mutant with brain morphological changes. IEEE Transactions on Information Technology in BioMedicine 2009, 13, 629-635.
7. Yu, D.; Pham, T. D.; Yan, H.; Zhang, B.; Crane, D. I. Segmentation of cultured neurons using logical analysis of grey and distance difference. J Neurosci Methods 2007.
8. Nguyen, T.; Bjorkman, J.; Paton, B. C.; Crane, D. I. Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance. J Cell Sci 2006, 119, 636-45.
9. Pham, T.; Crane, D. Segmentation of neuronal-cell images from stained fields and monomodal histograms. Conf Proc IEEE Eng Med Biol Soc 2005, 6, 6289-92.
10. Maxwell, M. A.; Leane, P. B.; Paton, B. C.; Crane, D. I. Novel PEX1 coding mutations and 5' UTR regulatory polymorphisms. Hum Mutat 2005, 26, 279.
11. Crane, D. I.; Maxwell, M. A.; Paton, B. C. PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders. Hum Mutat 2005, 26, 167-75.
12. Pham, T. D.; Crane, D. I.; Tran, T. H.; Nguyen, T. H. Extraction of fluorescent cell puncta by adaptive fuzzy segmentation. Bioinformatics 2004, 20, 2189-96.
13. Maxwell, M.; Bjorkman, J.; Nguyen, T.; Sharp, P.; Finnie, J.; Paterson, C.; Tonks, I.; Paton, B. C.; Kay, G. F.; Crane, D. I. Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype. Mol Cell Biol 2003, 23, 5947-57.
14. Kaarbo, M.; Crane, D. I.; Murrell, W. G. RhoA is highly up-regulated in the process of early heart development of the chick and important for normal embryogenesis. Dev Dyn 2003, 227, 35-47.
15. Maxwell, M. A.; Allen, T.; Solly, P. B.; Svingen, T.; Paton, B. C.; Crane, D. I. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients. Hum Mutat 2002, 20, 342-51.
16. Bjorkman, J.; Tonks, I.; Maxwell, M. A.; Paterson, C.; Kay, G. F.; Crane, D. I. Conditional inactivation of the peroxisome biogenesis Pex13 gene by Cre-loxP excision. Genesis 2002, 32, 179-80.
17. Bjorkman, J.; Gould, S. J.; Crane, D. I. Pex13, the mouse ortholog of the human peroxisome biogenesis disorder PEX13 gene: gene structure, tissue expression, and localization of the protein to peroxisomes. Genomics 2002, 79, 162-8.
18. Sneesby, K. J.; Crane, D. I.; Murrell, W. G. Characterisation of a cDNA encoding chick eukaryotic translation initiation factor-2 beta. DNA Seq 2001, 12, 59-65.
19. Lewohl, J. M.; Huygens, F.; Crane, D. I.; Dodd, P. R. GABA(A) receptor alpha-subunit proteins in human chronic alcoholics. J Neurochem 2001, 78, 424-34.
20. Urquhart, A. J.; Kennedy, D.; Gould, S. J.; Crane, D. I. Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p. J Biol Chem 2000, 275, 4127-36.
21. McIntyre, H. D.; Serek, R.; Crane, D. I.; Veveris-Lowe, T.; Parry, A.; Johnson, S.; Leung, K. C.; Ho, K. K.; Bougoussa, M.; Hennen, G.; Igout, A.; Chan, F. Y.; Cowley, D.; Cotterill, A.; Barnard, R. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab 2000, 85, 1143-50.
22. Kaarbo, M.; Crane, D. I.; Murrell, W. G. Isolation and characterisation of a chick cDNA encoding the RNA polymerase common subunit RPB6. DNA Seq 2000, 11, 155-62.
23. Watters, D.; Kedar, P.; Spring, K.; Bjorkman, J.; Chen, P.; Gatei, M.; Birrell, G.; Garrone, B.; Srinivasa, P.; Crane, D. I.; Lavin, M. F. Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem 1999, 274, 34277-82.
24. Maxwell, M. A.; Nelson, P. V.; Chin, S. J.; Paton, B. C.; Carey, W. F.; Crane, D. I. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype. Hum Genet 1999, 105, 38-44.
25. Liu, Y.; Bjorkman, J.; Urquhart, A.; Wanders, R. J.; Crane, D. I.; Gould, S. J. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. Am J Hum Genet 1999, 65, 621-34.
26. Masters, C.; Crane, D. On the role of the peroxisome in cell differentiation and carcinogenesis. Mol Cell Biochem 1998, 187, 85-97.
27. Bjorkman, J.; Stetten, G.; Moore, C. S.; Gould, S. J.; Crane, D. I. Genomic structure of PEX13, a candidate peroxisome biogenesis disorder gene. Genomics 1998, 54, 521-8.
28. Lewohl, J. M.; Crane, D. I.; Dodd, P. R. Expression of the alpha 1, alpha 2 and alpha 3 isoforms of the GABAA receptor in human alcoholic brain. Brain Res 1997, 751, 102-12.
29. Lewohl, J. M.; Crane, D. I.; Dodd, P. R. Zolpidem binding sites on the GABA(A) receptor in brain from human cirrhotic and non-cirrhotic alcoholics. Eur J Pharmacol 1997, 326, 265-72.
30. Lewohl, J. M.; Crane, D. I.; Dodd, P. R. A method for the quantitation of the alpha 1, alpha 2, and alpha 3 isoforms of the GABAA receptor in human brain using competitive PCR. Brain Res Brain Res Protoc 1997, 1, 347-56.
31. Paton, B. C.; Sharp, P. C.; Crane, D. I.; Poulos, A. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects. J Clin Invest 1996, 97, 681-8.
32. Masters, C.; Crane, D. Recent developments in peroxisome biology. Endeavour 1996, 20, 68-73.
33. Lewohl, J. M.; Crane, D. I.; Dodd, P. R. Alcohol, alcoholic brain damage, and GABAA receptor isoform gene expression. Neurochem Int 1996, 29, 677-84.
34. Gould, S. J.; Kalish, J. E.; Morrell, J. C.; Bjorkman, J.; Urquhart, A. J.; Crane, D. I. Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTs1 receptor. J Cell Biol 1996, 135, 85-95.
35. Dodd, P. R.; Thomas, G. J.; McCloskey, A.; Crane, D. I.; Smith, I. D. The neurochemical pathology of thiamine deficiency: GABAA and glutamateNMDA receptor binding sites in a goat model. Metab Brain Dis 1996, 11, 39-54.
36. Distel, B.; Erdmann, R.; Gould, S. J.; Blobel, G.; Crane, D. I.; Cregg, J. M.; Dodt, G.; Fujiki, Y.; Goodman, J. M.; Just, W. W.; Kiel, J. A.; Kunau, W. H.; Lazarow, P. B.; Mannaerts, G. P.; Moser, H. W.; Osumi, T.; Rachubinski, R. A.; Roscher, A.; Subramani, S.; Tabak, H. F.; Tsukamoto, T.; Valle, D.; van der Klei, I.; van Veldhoven, P. P.; Veenhuis, M. A unified nomenclature for peroxisome biogenesis factors. J Cell Biol 1996, 135, 1-3.
37. Murrell, W. G.; Masters, C. J.; Willis, R. J.; Crane, D. I. Chromatin structure and the expression of cardiac genes. Mech Ageing Dev 1995, 82, 1-17.
38. Masters, C. J.; Crane, D. I. On the role of the peroxisome in ontogeny, ageing and degenerative disease. Mech Ageing Dev 1995, 80, 69-83.
39. Chen, N.; Lu, Z.; Land, M.; Ayres, R.; Crane, D. I. Peroxisomal membrane protein PMP68 of mouse liver: cloning of a cDNA encompassing the nucleotide binding fold and epitope mapping of monoclonal antibodies to the expressed protein. Arch Biochem Biophys 1995, 321, 526-30.
40. Murrell, W. G.; Masters, C. J.; Willis, R. J.; Crane, D. I. On the ontogeny of cardiac gene transcripts. Mech Ageing Dev 1994, 77, 109-26.
41. Murrell, W.; Crane, D.; Masters, C. Developmental variations in the interactions of pyruvate kinase and glyceraldehyde-3-phosphate dehydrogenase with subcellular structure in cavian tissues. Mech Ageing Dev 1994, 74, 177-201.
42. Crane, D. I.; Kalish, J. E.; Gould, S. J. The Pichia pastoris PAS4 gene encodes a ubiquitin-conjugating enzyme required for peroxisome assembly. J Biol Chem 1994, 269, 21835-44.
43. Crane, D. I.; Gould, S. J. The Pichia pastoris HIS4 gene: nucleotide sequence, creation of a non-reverting his4 deletion mutant, and development of HIS4-based replicating and integrating plasmids. Curr Genet 1994, 26, 443-50.
44. Murrell, W.; Crane, D.; Masters, C. Ontogenic activities and interactions of the lactate dehydrogenase isozymes with cellular structure in the guinea pig. Mech Ageing Dev 1993, 69, 37-52.
45. Hughes, J. L.; Crane, D. I.; Robertson, E.; Poulos, A. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders. Virchows Arch A Pathol Anat Histopathol 1993, 423, 459-68.
46. Poole, C. B.; Crane, D. I. Protein organization in mouse liver peroxisomes. Arch Biochem Biophys 1992, 292, 605-12.
47. Murrell, W.; Crane, D.; Masters, C. Ontogenic characteristics of cavian aldolase. Mech Ageing Dev 1992, 65, 35-50.
48. Hughes, J. L.; Poulos, A.; Crane, D. I.; Chow, C. W.; Sheffield, L. J.; Sillence, D. Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata. Eur J Pediatr 1992, 151, 829-36.
49. Chen, N.; Crane, D. I. Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators. Biochem J 1992, 283 ( Pt 2), 605-10.
50. Klucis, E.; Crane, D. I.; Hughes, J. L.; Poulos, A.; Masters, C. J. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate. Biochim Biophys Acta 1991, 1074, 294-301.
51. Rohde, M.; Srivastava, G.; Rylatt, D. B.; Bundesen, P.; Zamattia, J.; Crane, D. I.; May, B. K. Immunocytochemical studies on the localization of 5-aminolevulinate synthase in rat liver. Arch Biochem Biophys 1990, 280, 331-5.
52. Masters, C.; Crane, D. Isozymes and the micro organization of organellar structure and function. Prog Clin Biol Res 1990, 344, 101-22.
53. Crane, D. I.; Zamattia, J.; Masters, C. J. Alterations in the integrity of peroxisomal membranes in livers of mice treated with peroxisome proliferators. Mol Cell Biochem 1990, 96, 153-61.
54. Pegg, M.; Crane, D.; Masters, C. On the interactions of catalase with subcellular structure. Mol Cell Biochem 1989, 86, 77-85.
55. Crane, D. I.; Chen, N. H.; Masters, C. J. Evidence that the enoyl-CoA hydratase bifunctional protein of mouse liver peroxisomes is identical with the 70,000 dalton peroxisomal membrane protein. Biochem Biophys Res Commun 1989, 160, 503-8.
56. Hemsley, A.; Pegg, M.; Crane, D.; Masters, C. On the compartmentalization of catalase, fatty acyl-CoA oxidase and urate oxidase in mammalian livers, and the influence of clofibrate treatment on this microlocalization. Mol Cell Biochem 1988, 83, 187-94.
57. Crane, D. I.; Chen, N.; Masters, C. Changes to the integral membrane protein composition of mouse liver peroxisomes in response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate. Mol Cell Biochem 1988, 81, 29-36.
58. Chen, N. H.; Crane, D. I.; Masters, C. J. Analysis of the major integral membrane proteins of peroxisomes from mouse liver. Biochim Biophys Acta 1988, 945, 135-44.
59. Pegg, M.; Crane, D.; Masters, C. Confirmation that catalase is a glycoprotein. Biochem Int 1986, 12, 831-8.
60. Masters, C.; Pegg, M.; Crane, D. On the multiplicity of the enzyme catalase in mammalian liver. Mol Cell Biochem 1986, 70, 113-20.
61. Crane, D. I.; Masters, C. J. The effect of clofibrate on the phospholipid composition of the peroxisomal membranes in mouse liver. Biochim Biophys Acta 1986, 876, 256-63.
62. Kilworth, L.; Crane, D.; Masters, C. The influence of insulin on the flux of lipid metabolism in vivo. Biochem Int 1985, 10, 539-47.
63. Crane, D. I.; Hemsley, A. C.; Masters, C. J. Purification of peroxisomes from livers of normal and clofibrate-treated mice. Anal Biochem 1985, 148, 436-45.
64. Masters, C.; Crane, D. On the role of peroxisomes in the metabolism of lipids--evidence from studies on mammalian tissues in vivo. Mol Cell Biochem 1984, 65, 23-35.
65. Klucis, E.; Crane, D.; Masters, C. Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs. Mol Cell Biochem 1984, 65, 73-82.
66. Kilworth, L.; Crane, D.; Masters, C. Relationships between the flux of lipid metabolism in vivo and the uncoupling of respiratory control. Biochem Int 1984, 8, 793-802.
67. Kilworth, L.; Crane, D.; Masters, C. On the flux of lipid metabolism in diabetic animals. Biochem Int 1984, 9, 745-53.
68. Crane, D.; Masters, C. On the role of catalase in the oxidation of tissue fatty acids. Arch Biochem Biophys 1984, 229, 104-11.
69. Sies, H.; Graf, P.; Crane, D. Decreased flux through pyruvate dehydrogenase during calcium ion movements induced by vasopressin, alpha-adrenergic agonists and the ionophore A23187 in perfused rat liver. Biochem J 1983, 212, 271-8.
70. Haussinger, D.; Crane, D.; Gerok, W.; Sies, H. Decrease of flux through pyruvate dehydrogenase and branched-chain 2-oxo-acid dehydrogenase by nitrofurantoin in perfused rat liver. Hoppe Seylers Z Physiol Chem 1983, 364, 1439-46.
71. Crane, D.; Holmes, R.; Masters, C. On the synthesis and incorporation of catalase and urate oxidase into the peroxisomes of mouse liver. Int J Biochem 1983, 15, 1429-37.
72. Crane, D.; Haussinger, D.; Graf, P.; Sies, H. Decreased flux through pyruvate dehydrogenase by thiol oxidation during t-butyl hydroperoxide metabolism in perfused rat liver. Hoppe Seylers Z Physiol Chem 1983, 364, 977-87.
73. Crane, D.; Holmes, R.; Masters, C. J. Synthesis and incorporation of phospholipid by peroxisomes of mouse liver. Biochim Biophys Acta 1982, 712, 57-64.
74. Crane, D.; Holmes, R.; Masters, C. Proteolytic modification of mouse liver catalase. Biochem Biophys Res Commun 1982, 104, 1567-72.
75. Crane, D.; Haussinger, D.; Sies, H. Rise of coenzyme A-glutathione mixed disulfide during hydroperoxide metabolism in perfused rat liver. Eur J Biochem 1982, 127, 575-8.
76. Crane, D.; Masters, C. On the turnover of tissue lipids in the mouse during dietary deprivation. Int J Biochem 1981, 13, 117-20.
77. Crane, D.; Holmes, R.; Masters, C. The influence of ethanol on lipid metabolism in mouse tissues. Int J Biochem 1981, 13, 395-9.
78. Crane, D.; Holmes, R.; Masters, C. The intracellular inactivation of catalase--II. Characteristics of a cytosol inhibitor in mouse liver. Int J Biochem 1980, 11, 595-603.
79. Crane, D.; Holmes, R.; Masters, C. The intracellular inactivation of catalase--I. Subcellular localization and inhibition in mouse liver. Int J Biochem 1980, 11, 587-93.
80. Crane, D.; Holmes, R.; Masters, C. The influence of clofibrate on lipid turnover in mouse tissues. Biochem Biophys Res Commun 1980, 93, 258-63.
81. Crane, D.; Holmes, R. S.; Masters, C. J. On the relative rates of synthesis and degradation of catalase in vertebrate tissues. Int J Biochem 1978, 9, 589-96.